Melanoma Journal Articles for January 2018

Ophthalmology

Conjunctival amelanotic malignant melanoma arising in primary acquired melanosis sine pigmento

MD Venita Jay and MD Ramon L. Font
https://doi.org/10.1016/S0161-6420(98)92156-X


Annals of Surgical Oncology

Melanoma Surveillance Strategies: Different Approaches to a Shared Goal

Keisuke Shirai and Sandra L. Wong
First Online: 02 January 2018
DOI https://doi.org/10.1245/s10434-017-6321-5


The New England Journal of Medicine

Management of Sentinel-Node Metastasis in Melanoma

Lisa Caulley, M.D., M.P.H., Charles M. Balch, M.D., Merrick I. Ross, M.D., and Caroline Robert, M.D., Ph.D.
N Engl J Med 2018; 378:85-88January 4, 2018DOI: 10.1056/NEJMclde1712449


Identification and functional analysis of SOX10 phosphorylation sites in melanoma

Julia C. Cronin, Stacie K. Loftus, Laura L. Baxter, Steve Swatkoski, Marjan Gucek, William J. Pavan


Future Oncol. 2018 Jan 10. doi: 10.2217/fon-2017-0525. [Epub ahead of print]

Are redheads at an increased risk of melanoma?

Miao X1Chen S2Zhu B2Yin C2Li X1Han C1Cui R2Li B1.


Acta Cytologica

Novel Insights from Clinical Practice

Cytologic Features of Malignant Melanoma with Osteoclast-Like Giant Cells
Jiménez-Heffernan J.A.a, c · Adrados M.a · Muñoz-Hernández P.a · Fernández-Rico P.a ·Ballesteros-García A.I.b · Fraga J.a, c
https://doi.org/10.1159/000486027


Nature. 2018 Jan 10. doi: 10.1038/nature25187. [Epub ahead of print]

High response rate to PD-1 blockade in desmoplastic melanomas.

Eroglu Z1,2Zaretsky JM1Hu-Lieskovan S1Kim DW2,3Algazi A4Johnson DB5Liniker E6Ben Kong7Munhoz R8,9Rapisuwon S10Gherardini PF11Chmielowski B1Wang X1Shintaku IP1Wei C1Sosman JA5Joseph RW12Postow MA8,9Carlino MS6,7,13Hwu WJ3Scolyer RA6,13,14Messina J2Cochran AJ1Long GV6,13,15Ribas A1.


Lasers Surg Med. 2018 Jan 13. doi: 10.1002/lsm.22786. [Epub ahead of print]

Noninvasive optical spectroscopy for identification of non-melanoma skin cancer: Pilot study.

Carpenter DJ1Sajisevi MB2Chapurin N1Brown CS3Cheng T1Palmer GM4Stevenson DS5Rao CL6Hall RP6Woodard CR3.


Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports

Stefan Schliep, Abbas Agaimy, Alexander Cavallaro, Franklin Kiesewetter, Gerold Schuler and Lucie Heinzerling
Journal for ImmunoTherapy of Cancer20186:2
https://doi.org/10.1186/s40425-017-0309-3
Received: 9 May 2017
Accepted: 10 December 2017
Published: 15 January 2018


CANCER RESEARCH
Tumor Biology and Immunology

Interferon-? Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4

Xuan Mo, Hanghang Zhang, Sarah Preston, Kayla Martin, Bo Zhou, Nish Vadalia, Ana M. Gamero, Jonathan Soboloff, Italo Tempera and M. Raza Zaidi
DOI: 10.1158/0008-5472.CAN-17-1615 Published January 2018


Ocular Oncology and pathology

Novel Insights from Clinical Practice

Successive Uveal Melanomas with Different Gene Expression Profiles in an Eye with Ocular Melanocytosis
Glaser T. · Thomas A.S. · Materin M.A. 

https://doi.org/10.1159/000484937Ocul Oncol Pathol 2018;4:236-239


Pigment Cell & Melanoma Research

The Next Generation of Melanocyte Data: Genetic, Epigenetic and Transcriptional Resource Datasets and Analysis Tools

  • Stacie K Loftus
  • Accepted manuscript online: 16 January 2018
  • DOI: 10.1111/pcmr.12687

The Lancet, Oncology

Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis

Julia A Beaver, MD, Maitreyee Hazarika, MD, Flora Mulkey, MSSirisha Mushti, PhD, Huanyu Chen, PhD, Kun He, PhD, Rajeshwari Sridhara, PhD, Kirsten B Goldberg, MA, Meredith K Chuk, MD, Dow-Chung Chi, MD, Jennie Chang, PharmD, Amy Barone, MD, Sanjeeve Balasubramaniam, MD, Gideon M Blumenthal, MD, Patricia Keegan, MD, Richard Pazdur, MD, Marc R Theoret, MD
Published: 17 January 2018
DOI: http://dx.doi.org/10.1016/S1470-2045(17)30846-X


Cancer Discovery

Patients with Desmoplastic Melanoma May Respond to PD-1 Blockade

Published OnlineFirst January 19, 2018
DOI: 10.1158/2159-8290.CD-RW2018-012


“Multiples Gastric Metastases of Malignant Melanoma”. EC Gastroenterology and Digestive System 5.2 (2018): 48-51. Received: December 15, 2017; Published: January 19, 2018
Kounpielime Sosthene Somda1*, Aboubacar Coulibaly1, Nomtondo Amina Ouedraogo2, Mali Koura4, Aime Sosthene Ouedraogo3, Christiane Couna Bere Some1, Armand Tapsoba1, Abdel Karim Serme1 and Alain Bougouma1 1


Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?

Harun Badakhshi, Fidelis Engeling, Volker Budach, Pirus Ghadjar, Sebastian Zschaeck and David Kaul
Radiation Oncology201813:3
https://doi.org/10.1186/s13014-017-0951-4
Received: 8 September 2017
Accepted: 29 December 2017
Published: 10 January 2018


M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma

Magdalena Jarosz-Biej , Natalia Kami?ska, Sybilla Matuszczak, Tomasz Cicho?, Jolanta Pamu?a-Pi?at, Justyna Czapla, Ryszard Smolarczyk, Daria Skwarzy?ska, Klaudia Kulik, Stanis?aw Szala
Published: January 10, 2018
https://doi.org/10.1371/journal.pone.0191012


Dove Press

Optical coherence tomography angiography in choroidal melanoma and nevus

Authors Ghassemi F, Mirshahi R, Fadakar K, Sabour S
Received 11 August 2017
Accepted for publication 26 September 2017
Published 22 January 2018 Volume 2018:12 Pages 207—214
DOI https://doi.org/10.2147/OPTH.S148897


Clinical Cancer Research
Cancer Therapy: Clinical

Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study

Michael B. Atkins, F. Stephen Hodi, John A Thompson, David McDermott, Wen-Jen Hwu, Donald P. Lawrence, Nancy A Dawson, Deborah Jean Lee Wong, Shailender Bhatia, Marihella James, Lokesh Jain, Seth Robey, Xinxin Shu, Blanca Homet Moreno, Rodolfo F Perini, Toni K. Choueiri and Antoni Ribas
DOI: 10.1158/1078-0432.CCR-17-3436


Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:394632017739531. doi: 10.1177/0394632017739531.

Tea polyphenols inhibit the proliferation, migration, and invasion of melanoma cells through the down-regulation of TLR4.

Chen X1Chang L2Qu Y1Liang J1Jin W1Xia X1.


Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2

Isabella C Glitza, Michelle Rohlfs, Nandita Guha-Thakurta, Roland L Bassett, Chantale Bernatchez, Adi Diab, Scott E Woodman, Cassian Yee, Rodabe N Amaria, Sapna P Patel, Hussein Tawbi, Michael Wong, Wen-Jen Hwu, Patrick Hwu, Amy Heimberger, Ian E McCutcheon, Nicholas Papadopoulos, Michael A Davies
DOI: 10.1136/esmoopen-2017-000283 Published 24 January 2018


Int. J. Mol. Sci. 201819(2), 255; doi:10.3390/ijms19020255

Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies

Nausicaa Clemente, Benedetta Ferrara, Casimiro Luca Gigliotti, Elena Boggio, Maria Teresa Capucchio, Elena Biasibetti, Davide Schiffer, Marta Mellai, Laura Annovazzi, Luigi Cangemi, Elisabetta Muntoni, Gianluca Miglio, Umberto Dianzani, Luigi Battaglia and Chiara Dianzani 
Received: 20 December 2017 / Revised: 11 January 2018 / Accepted: 18 January 2018 / Published: 24 January 2018
(This article belongs to the Special Issue Nanotechnology in Drug Delivery)


Int. J. Mol. Sci. 201819(2), 332; doi:10.3390/ijms19020332 (registering DOI)

Visualization and Quantitative 3D Analysis of Intraocular Melanoma and Its Vascularization in a Hamster Eye

Bartosz Leszczy?ski, Martyna ?niegocka, Andrzej Wróbel, Roman P?drys, Ma?gorzata Szczygie?, Bo?ena Romanowska-Dixon, Krystyna Urba?ska And Martyna Elas
Received: 31 December 2017 / Revised: 16 January 2018 / Accepted: 18 January 2018 / Published: 24 January 2018
(This article belongs to the Special Issue Animal Models of Melanoma)


American Journal of Neuroradiology

Melanoma of the Sinonasal Tract: Value of a Septate Pattern on Precontrast T1-Weighted MR Imaging

Y.-K. Kim, J.W. Choi, H.-J. Kim, H.Y. Kim, G.M. Park, Y.-H. Ko, J. Cha and S.T. Kim
American Journal of Neuroradiology January 2018, DOI: https://doi.org/10.3174/ajnr.A5539


Cancer Biol Ther. 2018 Jan 25:1-9. doi: 10.1080/15384047.2017.1414756. [Epub ahead of print]

Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.

Liu J1Qu X1Shao L1Hu Y1Yu X1Lan P1Guo Q1Han Q1Zhang J1Zhang C1.
PMID:29370558
DOI:10.1080/15384047.2017.1414756


Signal Transduction

Nanoscale Tuning of VCAM-1 Determines VLA-4–Dependent Melanoma Cell Plasticity on RGD Motifs

Katharina Amschler , Eugen Kossmann , Luise Erpenbeck , Sebastian Kruss , Tillmann Schill , Margarete Schon , Sigrid M.C. Mockel , Joachim P. Spatz, and Michael P. Schon
Published Online First 8 December, 2017 DOI: 10.1158/1541-7786.MCR-17-0272


Oncology Letters

Prognostic and clinicopathological value of melanoma-associated antigen D4 in patients with glioma

Jun Yan, Jing Wen, ZongDang Wei, XiSheng Li, Ping Li, ShaoWen Xiao
Published online on: January 26, 2018     https://doi.org/10.3892/ol.2018.7884


Chemical Communications

Evolutionary selection of personalized melanoma cell/tissue dual-homing peptides for guiding bionanofibers to malignant tumors

Mingying Yang,*a  Yan Li,b  Yanyan Huai,b  Chenyuan Wang,c  Wenfang Yid  and  Chuanbin Mao
The article was received on 25 Nov 2017, accepted on 16 Jan 2018 and first published on 26 Jan 2018
DOI: 10.1039/C7CC09077C


Cancer Immunology Research

YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma

Min Hwan Kim, Chang Gon Kim, Sang-Kyum Kim, Sang Joon Shin, Eun Ah Choe, Su-Hyung Park, Eui-Cheol Shin and Joon Kim
DOI: 10.1158/2326-6066.CIR-17-0320
Published OnlineFirst January 30, 2018


PNAS

Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking

David Taggart, Tereza Andreou, Karen J. Scott, Jennifer Williams, Nora Rippaus, Rebecca J. Brownlie, Elizabeth J. Ilett, Robert J. Salmond, Alan Melcher and Mihaela Lorger
PNAS 2018; published ahead of print January 31, 2018, https://doi.org/10.1073/pnas.1714089115


Neuro-Oncology

Radiosurgery for malignant melanoma brain polymetastasis

Sara Meade Charles Fong Geoff Heyes Rosemary Simmons Ruth StangeTimothy Jackson Helen Benghiat Garth Cruickshank Neil Steven Paul Sanghera …Show more

Neuro-Oncology, Volume 20, Issue suppl_1, 31 January 2018, Pages i12,
https://doi.org/10.1093/neuonc/nox238.050
Published: 31 January 2018


Pathology International

Nuclear pseudoinclusions in melanoma cells: prognostic fact or artifact? The possible role of Golgi phosphoprotein 3 overexpression in nuclear pseudoinclusions generation

Piotr Donizy, Maciej Kaczorowski, Przemyslaw Biecek, Agnieszka Halon, Rafal Matkowski

First published: 29 January 2018
DOI: 10.1111/pin.12629


The Lancet, Oncology

Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis

Julia A Beaver, MD, Maitreyee Hazarika, MD, Flora Mulkey, MS, Sirisha Mushti, PhD, Huanyu Chen, PhD, Kun He, PhD, Rajeshwari Sridhara, PhD, Kirsten B Goldberg, MA, Meredith K Chuk, MD, Dow-Chung Chi, MD, Jennie Chang, PharmD, Amy Barone, MD, Sanjeeve Balasubramaniam, MD, Gideon M Blumenthal, MD, Patricia Keegan, MD, Richard Pazdur, MD, Marc R Theoret, MD
Volume 19, No. 2, p229–239, February 2018
DOI: https://doi.org/10.1016/S1470-2045(17)30846-X


Archives of Dermatological Research

Subcutaneous injection of multipotent mesenchymal stromal cells admixed with melanoma cells in mice favors tumor incidence and growth: a systematic review and meta-analysis

Marcos Freitas Cordeiro, Luana Patricia Marmitt, Ana Paula Horn
Original Paper. DOI: https://doi.org/10.1007/s0040
First Online: 03 February 2018
 

Menu